The biopharmaceutical company is the maker of Thalomid and various other drugs that treat multimple myeloma, inflammatory diseases, and various forms of cancer.
News about Celgene
Hospitals win, health insurers not so much.
At least when it comes to market value.
Including Boeing and Pfizer
Trump's wish list will face a number of hurdles.